logo
After Soaring 40% in July, Is It Too Late to Buy This Supercharged Quantum Computing Stock?

After Soaring 40% in July, Is It Too Late to Buy This Supercharged Quantum Computing Stock?

Globe and Mail27-07-2025
Key Points
Rigetti Computing announced a breakthrough with its multichip system.
2030 is a key turning point for quantum computing.
10 stocks we like better than Rigetti Computing ›
Rigetti Computing (NASDAQ: RGTI) has had a phenomenal July, with the stock up around 40% at the time of writing, although it was up around 50% just a few days ago. Most investors would be pleased with that return over a multiyear time frame, let alone one year. However, considering the reason behind Rigetti Computing's rapid rise, this could be the beginning of an even larger movement.
Last week, Rigetti announced a breakthrough with its Ankaa-3 system, which caused shares to soar on the announcement. This spike wasn't for nothing. Rigetti announced a real breakthrough that could vault it into the leadership position in the quantum computing race.
Rigetti's breakthrough shows it's on the right track
Rigetti Computing announced that its Ankaa-3 system, which is composed of four 9-qubit chips, achieved a 99.5% two-qubit gate fidelity. This means that when a two-gate calculation is run, the computer delivers the correct answer 99.5% of the time. While this sounds impressive, it's still several orders of magnitude away from the accuracy of traditional computing, which is the fundamental problem companies in the quantum computing race are facing.
Instead of bits that use a 0 or 1 to transmit information, quantum computers utilize qubits, which are better described as the probability of an answer being a 0 or a 1. While the information collapses to a 0 or a 1 at the end of a computation, this can lead to some errors, which is why increasing accuracy is a key problem that these quantum computing companies must solve.
According to Rigetti Computing, its system is the largest multichip quantum computer available, vaulting it into a leadership position in this regard. However, there are several competitors with better two-qubit gate fidelity scores, so Rigetti Computing still has some work to do in this area.
Regardless, Rigetti Computing has made a significant breakthrough, demonstrating progress toward the practical relevance of quantum computing. However, how long will investors have to wait before it becomes a reality?
Rigetti's stock is a high-risk, high-reward investment
Prior to 2030, Rigetti Computing estimates that the annual demand will range from $1 billion to $2 billion, mostly driven by research institutions. After 2030, this market is expected to experience significant growth, with annual demand projected to reach $15 billion to $30 billion. The 2030 date isn't unique to Rigetti Computing; nearly every other quantum computing competitor has circled this date as a turning point within the quantum computing industry.
That's a long time from now, but is the market opportunity worth buying and holding a stock like Rigetti's?
Currently, Rigetti Computing has a market capitalization of approximately $5 billion. If it can capture a fraction of the market opportunity by 2030, say $2 billion, then its stock easily has room to double, if not triple, from today's prices.
A double or triple in the investing world over a five-year time frame is a phenomenal return, making this an attractive investment opportunity. However, there is another factor investors must be aware of.
Rigetti Computing's technology may fail in the future or be surpassed by another company offering similar technology. Because there is no backup plan for Rigetti Computing, this could cause the stock to fall to zero. Investors must be aware of the risk-reward profile with Rigetti's stock, as it could become worthless as easily as it doubles or triples.
As a result, quantum computing investors should ensure that a single company doesn't make up more than a 1% position within a portfolio. That way, if it goes to $0, it won't have as significant an impact on your returns. But if it doubles or triples, it can still have a sizable impact.
Time will tell if Rigetti Computing's strategy is a winning one, but its latest breakthrough shows investors that it's on the right track.
Should you invest $1,000 in Rigetti Computing right now?
Before you buy stock in Rigetti Computing, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rigetti Computing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!*
Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 21, 2025
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sterling Infrastructure: Navigating the Cycles of Construction and AI Growth
Sterling Infrastructure: Navigating the Cycles of Construction and AI Growth

Globe and Mail

time18 minutes ago

  • Globe and Mail

Sterling Infrastructure: Navigating the Cycles of Construction and AI Growth

Explore the exciting world of Sterling Infrastructure (NASDAQ: STRL) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities! *Stock prices used were the prices of Jul. 9, 2025. The video was published on Aug. 4, 2025. Should you invest $1,000 in Sterling Infrastructure right now? Before you buy stock in Sterling Infrastructure, consider this: Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Sterling Infrastructure wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* Now, it's worth noting Stock Advisor's total average return is 1,019% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025

KKR Prices $900,000,000 of 5.100% Senior Notes due 2035
KKR Prices $900,000,000 of 5.100% Senior Notes due 2035

Globe and Mail

timean hour ago

  • Globe and Mail

KKR Prices $900,000,000 of 5.100% Senior Notes due 2035

KKR & Co. Inc. ('KKR') (NYSE: KKR) today announced that it has priced its previously announced offering of $900,000,000 aggregate principal amount of its 5.100% Senior Notes due 2035 (the 'notes'). The notes will be senior obligations of KKR and will be fully and unconditionally guaranteed by KKR Group Partnership L.P. The offering is expected to close on August 7, 2025, subject to customary closing conditions. KKR intends to use the net proceeds from the sale of the notes for repurchase and refinancing of existing indebtedness of its subsidiary, KKR Financial Holdings LLC, and the remaining amount, if any, for general corporate purposes. Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc., KKR Capital Markets LLC and UBS Investment Bank are acting as joint book-running managers for the offering. The offering is being made pursuant to an effective shelf registration statement on file with the U.S. Securities and Exchange Commission (the 'SEC'). The offering is being made by means of a prospectus and related preliminary prospectus supplement only. An electronic copy of the preliminary prospectus supplement, together with the accompanying prospectus, is available on the SEC's website at Alternatively, copies of the preliminary prospectus supplement and accompanying prospectus may be obtained by contacting the joint book-running managers: Morgan Stanley & Co. LLC toll-free at 1-866-718-1649 or emailing prospectus@ Goldman Sachs & Co. LLC toll-free at 1-866-471-2526 or emailing prospectus-ny@ HSBC Securities (USA) Inc. toll-free at 1-866-811-8049; KKR Capital Markets LLC toll-free at 1-212-230-9433; or UBS Investment Bank toll-free at 1-833-481-0269. This press release shall not constitute an offer to sell or a solicitation of an offer to purchase the notes or any other securities, and shall not constitute an offer, solicitation or sale of the notes in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This press release contains certain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, pertaining to KKR. Forward-looking statements relate to expectations, estimates, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. These forward-looking statements can be identified by the use of words such as 'outlook,' 'believe,' 'think,' 'expect,' 'potential,' 'continue,' 'may,' 'should,' 'seek,' 'approximately,' 'predict,' 'intend,' 'will,' 'plan,' 'estimate,' 'anticipate,' 'visibility,' 'positioned,' 'path to,' 'conviction,' the negative version of these words, other comparable words or other statements that do not relate strictly to historical or factual matters. These forward-looking statements are based on KKR's beliefs, assumptions and expectations, but these beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to KKR or within its control. Due to various risks and uncertainties, actual events or results may differ materially from those reflected or contemplated in such forward-looking statements. We believe these factors include those in the sections entitled 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, as such factors may be updated from time to time in our periodic filings with the SEC, which are accessible on the SEC's website at These factors should be read in conjunction with the other cautionary statements that are included in our periodic filings. Past performance is no guarantee of future results. All forward-looking statements speak only as of the date of this press release. KKR does not undertake any obligation to update any forward-looking statements to reflect circumstances or events that occur after the date of this press release except as required by law.

Selloff? What Selloff? Monday Market Rebound
Selloff? What Selloff? Monday Market Rebound

Globe and Mail

timean hour ago

  • Globe and Mail

Selloff? What Selloff? Monday Market Rebound

Markets reversed Friday's selloff with relative ease today, hitting the tape in the green this morning and staying higher throughout the session. It's a clear bounce-back to start a new week of trading. The Dow gained +585 points, +1.34%, while the S&P 500 grew +91, +1.47%. The Nasdaq was up an impressive +403 points, +1.95% on the day, and the small-cap Russell 2000 beat the field: +44 points, +2.05%. Bond yields had already come down and they were steady today, as well: +4.20% on the 10-year and +3.69% on the 2-year. These are clear indicators that interest rates will need to come down — they are currently between +4.25-4.50%, as they have been all year so far. There is no August Fed meeting, however; unless an emergency arises, the Fed's next chance to lower rates will come September 17th. Factory Orders for June came in at negative levels, as expected, but 10 basis points (bps) better than expected at -4.8%. This follows the best single-month in factory orders for at least 10 years, an upwardly revised +8.3%. This clearly was a result of tariff and tariff deadline adjustments post-'Liberation Day' at the start of calendar Q2. A tariff reprieve gave companies (and individuals) the opportunity to load up ahead of any future unforeseen moves. Q2 Earnings After the Close Denver-based intelligence software firm Palantir Technologies PLTR posted robust numbers in its Q2 report after the closing bell sounded today, beating on its bottom line by only 2 cents to 16 cents per share, but revenues of $1.0 billion surging past the $938.3 million expected — a record high quarter on the top line. The U.S. grew +68%, commercial was up +93% and the government +53%. Palantir's revenue guidance for next quarter is well beyond prior estimates, for both next quarter and the full year. The low-end of revenue guidance of $1.083 billion for the quarter and $4.14 billion for the year were already well beyond the $989.4 million and $3.92 billion, respectively. Shares are up +4% currently, and the company expects 10x revenue growth over the next decade. We expect the company will be able to shake off its Zacks Rank #5 (Strong Sell) rating. Hims & Hers Health HIMS, on the other hand, came up short on both top and bottom lines this afternoon, with earnings of 17 cents per share missing the Zacks consensus by a penny, with revenues of $545 million below the $553.2 million expected. The company reaffirmed full-year guidance, but at +162% year to date, shares are trading off -12% in the after-market. Vertex Pharmaceuticals VRTX is off by an even more significant margin, -13.5%, even as the biopharma firm beat estimates on both top and bottom lines after today's close. One of its pain drugs in Phase 2 testing failed to meet its objectives and will be discontinued. CSO David Altshuler will also be stepping down from his post. What to Expect from the Stock Market Tomorrow Q2 earnings season hits full throttle Tuesday, with Caterpillar CAT, McDonald's MCD, big pharma Pfizer PFE and biotech Amgen AMGN all reporting ahead of the open, and chipmaker AMD AMD and EV upstart Rivian RIVN coming out with numbers after the close. The U.S. Trade Deficit will hit the tape Tuesday morning, expected to improve to -$61.0 billion from -$75.5 billion reported last time around. We'll also see S&P and ISM Services PMI once the market opens, expected to remain north of the 50-level, which depicts growth versus loss. Trade deals have gone quiet of late, but there's always a chance something new will be agreed upon, or signed. Questions or comments about this article and/or author? Click here>> Zacks Names #1 Semiconductor Stock This under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be. With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028. See This Stock Now for Free >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Advanced Micro Devices, Inc. (AMD): Free Stock Analysis Report Caterpillar Inc. (CAT): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock Analysis Report Amgen Inc. (AMGN): Free Stock Analysis Report McDonald's Corporation (MCD): Free Stock Analysis Report Vertex Pharmaceuticals Incorporated (VRTX): Free Stock Analysis Report Palantir Technologies Inc. (PLTR): Free Stock Analysis Report Hims & Hers Health, Inc. (HIMS): Free Stock Analysis Report Rivian Automotive, Inc. (RIVN): Free Stock Analysis Report

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store